An Open-Label, Dose-Escalation Study of IMC-20D7S In Participants With Malignant Melanoma

Clinical trial NCT01137006 · COMPLETED

Trial details

NCT number: NCT01137006
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2010-06-01
Primary completion: 2012-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.